about
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimeti...
Read More
18.06
-0.02
(-0.11%)
269.4K
XNAS Volume
XNAS 06 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for GlycoMimetics Inc is on 14 May 2026 for the purpose of GlycoMimetics Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
GlycoMimetics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..